{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260506078055/en/Viridian-Therapeutics-Announces-Pricing-of-Upsized-Concurrent-Public-Offerings-of-1.75-Convertible-Senior-Notes-Due-2032-and-Common-Stock-with-Aggregate-Gross-Proceeds-of-350.0-Million", "message": "News view counter 709069 successfully enlarged"}